DocGo Inc. (NASDAQ:DCGO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six research firms that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $3.56.
A number of equities analysts recently issued reports on DCGO shares. BTIG Research cut DocGo from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Canaccord Genuity Group restated a “hold” rating and set a $1.45 price objective (down previously from $5.00) on shares of DocGo in a report on Monday, May 12th. Finally, Needham & Company LLC dropped their price objective on DocGo from $4.00 to $3.00 and set a “buy” rating for the company in a report on Friday, May 9th.
View Our Latest Stock Analysis on DCGO
DocGo Stock Performance
DocGo (NASDAQ:DCGO – Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). The company had revenue of $96.03 million during the quarter, compared to analysts’ expectations of $104.25 million. DocGo had a positive return on equity of 2.52% and a negative net margin of 0.12%. Sell-side analysts predict that DocGo will post 0.25 earnings per share for the current fiscal year.
Institutional Investors Weigh In On DocGo
Several hedge funds have recently made changes to their positions in DCGO. Summit Securities Group LLC purchased a new stake in shares of DocGo in the 1st quarter worth $34,000. Summit Investment Advisors Inc. lifted its holdings in shares of DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after buying an additional 2,968 shares during the period. Prudential Financial Inc. purchased a new stake in shares of DocGo in the 4th quarter worth $55,000. Royce & Associates LP purchased a new stake in shares of DocGo in the 4th quarter worth $64,000. Finally, Strs Ohio purchased a new stake in shares of DocGo during the 1st quarter worth $76,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- Manufacturing Stocks Investing
- 3 Defense Leaders Set to Gain From Rising Military Spend
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why the Schwab Dividend ETF Rallied—and Can It Keep Climbing?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MarketBeat Week in Review – 06/30 – 07/04
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.